Executive Profiles

Founder and CEO, Bloodbuy

President, Global Vaccines, Merck & Co.

Senior Director, Consumer Scientific Innovation, Johnson & Johnson Innovation

Vice President and Head, Innovation Center, Global Health and Value, Pfizer Inc.

President, US Pharmaceuticals, Bayer

Senior Director of Sales Analytics and Operations, Gilead Sciences

Vice President, Business and Financial Planning, Merck & Co.

Vice President, US Payer & Institutional Strategy Lead, Shire

Pharm Exec’s 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable-or complacent.

Global Head, Drug Development, and Chief Medical Officer, Novartis

Vice President, Business Development, Regeneron Pharmaceuticals

Co-Founders, twoXAR

Vice President, Business Technology, Pfizer Inc.

Pharm Exec sits down with UBC President Patrick Lindsay to provide some real-world context around our 2016 feature profile of sixteen Emerging Leaders in biopharma.

Vice President, Psychiatry Marketing, Lundbeck US

Senior Director, Marketing, XenoPort

Managing Director, Singapore and Asian Emerging Markets, Novartis

Pharm Exec sits down with Anthony Marucci, co-founder and CEO of Celldex, a stealth player in the immunotherapy field.

Envigo's new CEO shares with Pharm Exec his vision for the company’s future, the changes he’s seen in the industry, and his thoughts on that thorny subject, Brexit.

Pharm Exec sits down with AmerisourceBergen supply chain leader Peyton Howell to discuss the latest trends in pharmaceutical distribution, including company efforts to boost efficiency, reliability, and enhance its groundbreaking partnership with Walgreens Boots Alliance.

Pharm Exec’s 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.

Pharm Exec sits down with Habib Dable, a 22-year veteran of Bayer, to discuss his few first months at the helm of the company’s US pharma operations, where he is leading Bayer’s repositioning as a drug innovator and advancing its “all-in” approach to product partnering.

Today’s powerful convergence of health data and technology is fun to watch unfold, but a focused vision on system and process integration-and the framework for continuous enrichment-will be key to future lasting gains for clinical research.

A conversation with GlaxoSmithKline's US Pharmaceuticals head Jack Bailey.

William Looney speaks with DIA's Global Chief Executive to see how the organization is repositioning itself as the go-to place for the independent insights in a business with no boundaries.